Zhang B, Wang C, Yang S, Li X, et al. A comparison of efficacy and prognosis between RC48 combined immunotherapy and gemcitabine-cisplatin combined immunotherapy in bladder-preserving multimodal therapy for muscle-invasive bladder cancer. Int Urol Nephrol 2026 Jul 25. doi: 10.1007/s11255-026-05275.
PMID: 42501246